Yahoo17d
Uncovering CT’s Past: Archaeologists still finding history in state
MANSFIELD — Although the United States is a fairly new country in comparison to others, it doesn’t mean its history is any less rich. The University of Connecticut Office of State Archaeology ...
Medscape23d
Drug Combo for Common Neuroendocrine Tumor: A New Standard?
This combination has “the potential to become a new standard first-line treatment” for well-differentiated grade 1/2 gastroenteropancreatic neuroendocrine tumors with poor prognostic factors ...
ascopubs.org23d
A first-in-human phase I trial with antibody drug conjugate ADCT-701 in neuroendocrine tumors and carcinomas.
Comparative outcomes of neuroendocrine tumors in the historically underserved population of Bronx, NY: Montefiore Einstein Comprehensive Cancer Center. Pamrevlumab ...
ascopubs.org23d
Nirogacestat in patients with desmoid tumors and mutations of adenomatous polyposis coli (APC): Findings from the DeFi trial.
Total neoadjuvant therapy with FOLFOX plus bevacizumab and short-course radiotherapy for Ras mutant, high-risk, locally advanced rectal cancer: The TRAINER trial. Phase Ib study of gevokizumab (GEVO) ...
Medical Xpress29d
Deep learning model helps detect lung tumors on CT scans
A new deep learning model shows promise in detecting and segmenting lung tumors, according to a study published today in Radiology. The findings of ... of lung tumors on CT scans is critical ...
MedPage Today29d
Big PFS Increase in Advanced Neuroendocrine Tumors With Combination Therapy
Opens in a new tab or window SAN FRANCISCO -- Progression-free survival (PFS) in gastroenteropancreatic neuroendocrine tumors (GEP-NETs) more than doubled with the addition of the somatostatin ...